Marie Elizabeth McDonnell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus | 33 | 2024 | 5815 | 3.360 |
Why?
|
Hyperglycemia | 15 | 2024 | 1368 | 2.880 |
Why?
|
Hypoglycemic Agents | 16 | 2024 | 3069 | 1.120 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2024 | 3432 | 0.950 |
Why?
|
Blood Glucose | 19 | 2024 | 6349 | 0.860 |
Why?
|
Diabetic Ketoacidosis | 2 | 2020 | 253 | 0.790 |
Why?
|
Insulin | 13 | 2022 | 6578 | 0.770 |
Why?
|
Diabetes Mellitus, Type 2 | 17 | 2024 | 12078 | 0.680 |
Why?
|
Diabetic Cardiomyopathies | 2 | 2018 | 89 | 0.680 |
Why?
|
Beverages | 2 | 2019 | 818 | 0.550 |
Why?
|
Diabetic Angiopathies | 2 | 2018 | 802 | 0.520 |
Why?
|
Diabetic Neuropathies | 2 | 2019 | 405 | 0.490 |
Why?
|
Toll-Like Receptors | 4 | 2010 | 589 | 0.470 |
Why?
|
Long-Term Care | 1 | 2018 | 632 | 0.460 |
Why?
|
Dietary Carbohydrates | 1 | 2019 | 890 | 0.460 |
Why?
|
Access to Information | 1 | 2016 | 316 | 0.440 |
Why?
|
Diabetes Complications | 2 | 2019 | 1317 | 0.430 |
Why?
|
Cost Sharing | 2 | 2015 | 409 | 0.420 |
Why?
|
B-Lymphocytes | 6 | 2015 | 4737 | 0.420 |
Why?
|
Patient Participation | 1 | 2021 | 1435 | 0.400 |
Why?
|
Perioperative Care | 4 | 2016 | 1023 | 0.400 |
Why?
|
Medicare Part D | 2 | 2015 | 353 | 0.390 |
Why?
|
Hospitalization | 7 | 2024 | 10634 | 0.390 |
Why?
|
Omentum | 1 | 2012 | 168 | 0.370 |
Why?
|
Medication Adherence | 5 | 2021 | 2155 | 0.370 |
Why?
|
Preoperative Care | 1 | 2019 | 2246 | 0.340 |
Why?
|
Insulin Resistance | 7 | 2024 | 3941 | 0.330 |
Why?
|
Postoperative Complications | 3 | 2019 | 15532 | 0.330 |
Why?
|
Practice Guidelines as Topic | 10 | 2024 | 7366 | 0.320 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2306 | 0.320 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 393 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3077 | 0.310 |
Why?
|
Telemedicine | 4 | 2022 | 3013 | 0.310 |
Why?
|
Blood Glucose Self-Monitoring | 5 | 2024 | 458 | 0.310 |
Why?
|
Hypoglycemia | 2 | 2016 | 881 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3197 | 0.310 |
Why?
|
Endocrinology | 5 | 2024 | 441 | 0.310 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7798 | 0.300 |
Why?
|
Metformin | 3 | 2024 | 905 | 0.300 |
Why?
|
Obesity | 11 | 2023 | 12870 | 0.300 |
Why?
|
Humans | 86 | 2024 | 757566 | 0.290 |
Why?
|
Breast Neoplasms | 3 | 2024 | 20992 | 0.280 |
Why?
|
Antithyroid Agents | 1 | 2006 | 72 | 0.270 |
Why?
|
Ethionamide | 1 | 2005 | 11 | 0.260 |
Why?
|
Intraoperative Complications | 1 | 2012 | 1165 | 0.250 |
Why?
|
Vitamin D | 3 | 2024 | 3282 | 0.220 |
Why?
|
Hospital Mortality | 4 | 2024 | 5243 | 0.220 |
Why?
|
Coronary Artery Bypass | 1 | 2012 | 2188 | 0.210 |
Why?
|
Atherosclerosis | 2 | 2019 | 3401 | 0.210 |
Why?
|
Internal Medicine | 1 | 2010 | 1048 | 0.210 |
Why?
|
Cytokines | 6 | 2015 | 7336 | 0.210 |
Why?
|
Phenylalanine | 1 | 2024 | 365 | 0.200 |
Why?
|
Vitamin D Deficiency | 3 | 2024 | 1377 | 0.200 |
Why?
|
Skin Pigmentation | 1 | 2024 | 276 | 0.200 |
Why?
|
Evidence-Based Medicine | 4 | 2022 | 3670 | 0.190 |
Why?
|
Middle Aged | 32 | 2024 | 219192 | 0.190 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4214 | 0.180 |
Why?
|
Prediabetic State | 2 | 2024 | 547 | 0.180 |
Why?
|
Body Weight | 1 | 2011 | 4602 | 0.180 |
Why?
|
Exercise Therapy | 1 | 2007 | 919 | 0.180 |
Why?
|
Hypothyroidism | 1 | 2005 | 665 | 0.180 |
Why?
|
Health Services Accessibility | 2 | 2018 | 5382 | 0.170 |
Why?
|
Cardiac Surgical Procedures | 2 | 2012 | 3603 | 0.170 |
Why?
|
Neoplasms | 4 | 2021 | 21986 | 0.170 |
Why?
|
Female | 39 | 2024 | 389943 | 0.170 |
Why?
|
Pregnancy in Diabetics | 1 | 2021 | 194 | 0.170 |
Why?
|
Personal Satisfaction | 1 | 2024 | 641 | 0.160 |
Why?
|
Thyroid Nodule | 1 | 2006 | 760 | 0.160 |
Why?
|
Quality Improvement | 2 | 2018 | 3793 | 0.160 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1400 | 0.150 |
Why?
|
Colitis, Ulcerative | 1 | 2010 | 1919 | 0.150 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1292 | 0.150 |
Why?
|
Patient Readmission | 3 | 2024 | 3241 | 0.150 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2354 | 0.150 |
Why?
|
Hypogonadism | 1 | 2024 | 798 | 0.150 |
Why?
|
Crohn Disease | 1 | 2010 | 2275 | 0.150 |
Why?
|
Carbohydrates | 1 | 2019 | 388 | 0.150 |
Why?
|
Aged | 23 | 2024 | 167890 | 0.140 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2005 | 930 | 0.140 |
Why?
|
Adult | 30 | 2024 | 219725 | 0.140 |
Why?
|
Antitubercular Agents | 1 | 2005 | 1373 | 0.140 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2016 | 43 | 0.140 |
Why?
|
Curriculum | 1 | 2010 | 3715 | 0.140 |
Why?
|
Retrospective Studies | 13 | 2024 | 79984 | 0.140 |
Why?
|
Male | 32 | 2024 | 358180 | 0.140 |
Why?
|
Vasodilation | 3 | 2010 | 960 | 0.130 |
Why?
|
Inpatients | 5 | 2020 | 2536 | 0.130 |
Why?
|
Risk Assessment | 2 | 2016 | 23816 | 0.130 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 15398 | 0.130 |
Why?
|
Biometry | 1 | 2018 | 560 | 0.120 |
Why?
|
Administration, Oral | 3 | 2015 | 3994 | 0.120 |
Why?
|
Receptor, erbB-2 | 2 | 2022 | 2552 | 0.120 |
Why?
|
Glucose | 2 | 2024 | 4336 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2021 | 626 | 0.120 |
Why?
|
Thiazoles | 1 | 2022 | 1511 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2024 | 58558 | 0.110 |
Why?
|
Pandemics | 4 | 2021 | 8600 | 0.110 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2208 | 0.110 |
Why?
|
Disease Management | 2 | 2021 | 2495 | 0.110 |
Why?
|
Self Care | 1 | 2018 | 793 | 0.100 |
Why?
|
Patient Discharge | 2 | 2018 | 3428 | 0.100 |
Why?
|
Orthopedic Procedures | 1 | 2022 | 1261 | 0.100 |
Why?
|
Infusions, Parenteral | 1 | 2012 | 398 | 0.100 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2013 | 125 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2144 | 0.100 |
Why?
|
Ambulatory Care | 3 | 2022 | 2767 | 0.100 |
Why?
|
Dyspnea | 1 | 2000 | 1344 | 0.100 |
Why?
|
General Practice | 1 | 2012 | 96 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1415 | 0.100 |
Why?
|
Dietary Supplements | 1 | 2024 | 3387 | 0.090 |
Why?
|
Insulin Infusion Systems | 1 | 2013 | 217 | 0.090 |
Why?
|
Diabetes, Gestational | 1 | 2021 | 1241 | 0.090 |
Why?
|
Body Mass Index | 4 | 2012 | 12868 | 0.090 |
Why?
|
Cushing Syndrome | 1 | 2012 | 241 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11057 | 0.090 |
Why?
|
Brachial Artery | 3 | 2010 | 365 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2742 | 0.090 |
Why?
|
Communication | 2 | 2021 | 3841 | 0.090 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5325 | 0.090 |
Why?
|
Postoperative Care | 2 | 2016 | 1468 | 0.090 |
Why?
|
Endothelium, Vascular | 4 | 2010 | 4427 | 0.080 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 116 | 0.080 |
Why?
|
Th17 Cells | 1 | 2015 | 785 | 0.080 |
Why?
|
HMGB1 Protein | 1 | 2010 | 137 | 0.080 |
Why?
|
Antigens, CD19 | 1 | 2012 | 423 | 0.080 |
Why?
|
Chronic Periodontitis | 1 | 2009 | 101 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2018 | 3579 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2969 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1399 | 0.080 |
Why?
|
Prognosis | 5 | 2022 | 29488 | 0.080 |
Why?
|
Saliva | 1 | 2012 | 820 | 0.080 |
Why?
|
Panniculitis | 1 | 2008 | 45 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2015 | 4338 | 0.080 |
Why?
|
Lupus Nephritis | 1 | 2011 | 318 | 0.070 |
Why?
|
Tibia | 1 | 2013 | 1065 | 0.070 |
Why?
|
Life Style | 1 | 2019 | 3886 | 0.070 |
Why?
|
Drug Costs | 1 | 2015 | 1179 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1892 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2009 | 906 | 0.070 |
Why?
|
Saphenous Vein | 1 | 2009 | 517 | 0.070 |
Why?
|
Abdominal Fat | 1 | 2008 | 221 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3415 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2016 | 22022 | 0.070 |
Why?
|
Benchmarking | 1 | 2012 | 1041 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2019 | 64242 | 0.060 |
Why?
|
Monocytes | 2 | 2015 | 2568 | 0.060 |
Why?
|
Myocardial Revascularization | 1 | 2009 | 792 | 0.060 |
Why?
|
Adipose Tissue | 2 | 2008 | 3298 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5483 | 0.060 |
Why?
|
Flow Cytometry | 3 | 2010 | 5861 | 0.060 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 2203 | 0.060 |
Why?
|
Logistic Models | 3 | 2017 | 13221 | 0.060 |
Why?
|
Risk Factors | 5 | 2024 | 73708 | 0.060 |
Why?
|
Anesthesia | 1 | 2016 | 1581 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2012 | 1802 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2006 | 522 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3309 | 0.060 |
Why?
|
Choristoma | 1 | 2006 | 206 | 0.060 |
Why?
|
Odds Ratio | 2 | 2015 | 9624 | 0.060 |
Why?
|
Appetite Depressants | 1 | 2024 | 108 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9263 | 0.060 |
Why?
|
Ligands | 1 | 2010 | 3257 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2006 | 1121 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2455 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3234 | 0.050 |
Why?
|
Weight Loss | 3 | 2010 | 2672 | 0.050 |
Why?
|
Length of Stay | 2 | 2016 | 6384 | 0.050 |
Why?
|
Iodine Radioisotopes | 1 | 2006 | 1032 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1806 | 0.050 |
Why?
|
Monitoring, Intraoperative | 1 | 2009 | 939 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2212 | 0.050 |
Why?
|
Postprandial Period | 1 | 2024 | 314 | 0.050 |
Why?
|
Appetite | 1 | 2024 | 247 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1879 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5068 | 0.050 |
Why?
|
Endocrine System | 1 | 2022 | 112 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6956 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11709 | 0.050 |
Why?
|
Qualitative Research | 3 | 2021 | 2973 | 0.050 |
Why?
|
Schizophrenia | 1 | 1999 | 6911 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11063 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2021 | 126 | 0.040 |
Why?
|
Phosphatidylinositols | 1 | 2021 | 282 | 0.040 |
Why?
|
Adipocytes | 1 | 2007 | 1178 | 0.040 |
Why?
|
Societies, Medical | 3 | 2024 | 3887 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 41190 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3440 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2475 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5489 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2690 | 0.040 |
Why?
|
NF-kappa B | 1 | 2008 | 2472 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3069 | 0.040 |
Why?
|
Thyroid Gland | 1 | 2006 | 1167 | 0.040 |
Why?
|
Critical Illness | 1 | 2012 | 2705 | 0.040 |
Why?
|
Technology | 1 | 2021 | 292 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Young Adult | 6 | 2017 | 58755 | 0.040 |
Why?
|
Prospective Studies | 4 | 2024 | 54092 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2024 | 748 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13597 | 0.040 |
Why?
|
Cambodia | 1 | 2018 | 185 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6292 | 0.040 |
Why?
|
Hospitals | 1 | 2010 | 3861 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12951 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 13952 | 0.030 |
Why?
|
Prostatectomy | 1 | 2024 | 1821 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15207 | 0.030 |
Why?
|
Androgens | 1 | 2023 | 1281 | 0.030 |
Why?
|
Adolescent | 5 | 2016 | 87819 | 0.030 |
Why?
|
Body Composition | 1 | 2024 | 2416 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2023 | 1516 | 0.030 |
Why?
|
Perioperative Period | 1 | 2016 | 249 | 0.030 |
Why?
|
Models, Organizational | 1 | 2018 | 546 | 0.030 |
Why?
|
Morbidity | 1 | 2000 | 1748 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1531 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 771 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.030 |
Why?
|
Macrophages | 1 | 2008 | 5732 | 0.030 |
Why?
|
C-Reactive Protein | 3 | 2010 | 3809 | 0.030 |
Why?
|
Testosterone | 1 | 2024 | 2465 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2781 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2443 | 0.030 |
Why?
|
Ireland | 1 | 2012 | 171 | 0.030 |
Why?
|
Inflammation | 4 | 2015 | 10709 | 0.030 |
Why?
|
Pakistan | 1 | 2013 | 292 | 0.030 |
Why?
|
Physician's Role | 1 | 2019 | 916 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2056 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 420 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2019 | 973 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2015 | 18936 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1067 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2859 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2212 | 0.020 |
Why?
|
Placenta | 1 | 2021 | 1703 | 0.020 |
Why?
|
General Practitioners | 1 | 2012 | 101 | 0.020 |
Why?
|
Periodicity | 1 | 2012 | 347 | 0.020 |
Why?
|
Accidental Falls | 1 | 2019 | 1056 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6230 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 39811 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2629 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2010 | 2375 | 0.020 |
Why?
|
Drugs, Generic | 1 | 2015 | 444 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2904 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9459 | 0.020 |
Why?
|
Internship and Residency | 1 | 2010 | 5854 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2019 | 1267 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4901 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1825 | 0.020 |
Why?
|
United States | 2 | 2015 | 71902 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7502 | 0.020 |
Why?
|
Toll-Like Receptor 1 | 1 | 2008 | 47 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2009 | 392 | 0.020 |
Why?
|
Lipopeptides | 1 | 2008 | 71 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1886 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2016 | 1521 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2010 | 696 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2009 | 856 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 282 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2008 | 251 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1339 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2008 | 344 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2004 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1666 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2007 | 939 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2012 | 2425 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 972 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9590 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2237 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5638 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2634 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10135 | 0.010 |
Why?
|
Signal Transduction | 1 | 2008 | 23335 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2010 | 907 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2010 | 1173 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2008 | 576 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9298 | 0.010 |
Why?
|
Decision Making | 1 | 2018 | 3909 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2847 | 0.010 |
Why?
|
Nitroglycerin | 1 | 2005 | 328 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 2005 | 320 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5412 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2357 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2008 | 12761 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2011 | 15781 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2009 | 722 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3154 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2568 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26176 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7927 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4760 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5856 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29712 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8502 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6070 | 0.010 |
Why?
|
Child | 2 | 2013 | 79782 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6457 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2008 | 3206 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 3996 | 0.010 |
Why?
|
Child, Preschool | 1 | 2000 | 42045 | 0.010 |
Why?
|
Gastric Bypass | 1 | 2005 | 817 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10075 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6757 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4338 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13463 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5951 | 0.010 |
Why?
|
Heart Failure | 1 | 2019 | 11595 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2006 | 4451 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2006 | 3806 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14637 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81066 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11469 | 0.010 |
Why?
|
Echocardiography | 1 | 2006 | 4963 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20499 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16533 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 25924 | 0.010 |
Why?
|
Animals | 2 | 2013 | 167718 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36270 | 0.000 |
Why?
|